Information
-
Trademark
-
79214474
-
Serial Number
79214474
-
Registration Number
5477867
-
International Classifications
-
Filing Date
November 10, 2016
7 years ago
-
Registration Date
May 29, 2018
6 years ago
-
Transaction Date
May 29, 2023
a year ago
-
Status Date
May 29, 2018
6 years ago
-
Published for Opposition Date
March 13, 2018
6 years ago
-
Location Date
May 29, 2018
6 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
STRUCK, ROBERT J
-
Attorney Docket Number
20040.0014US
Attorney Name
Michael D. Schumann
Law Office Assigned Location Code
L90
-
Owners
Mark Drawing Code
3000
Mark Identification
TASLY
Case File Statements
- DM0000: The mark consists of an outline of a shaded triangle with two cut-outs in the shape of horizontal bars crossing through the top half; a smaller shaded triangle appears inside. To the right of the triangles appears the literal element "TASLY".
- GS0051: Medicine for human purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Chemico-pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Raw material medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Biomedicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; pharmaceutical herbs for medical purposes; Prepared Chinese medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Capsules for medicines, namely, capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Dietetic food and beverages adapted for medical use; bath preparations, medicated; Medical analgesic preparations; preparations for the treatment of burns; Syrups for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; vitamin preparations; sunburn preparations for pharmaceutical purposes; vaccines; detergents for medical purposes; disinfectants for hygiene purposes; digestives for pharmaceutical purposes; mineral water for medical purposes; Mineral salts for medical purposes; purgatives; meal for pharmaceutical purposes; flour for pharmaceutical purposes; febrifuges; medicinal tea; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; anthelmintics; Pharmaceutical Gelatin, namely, gelatin capsules sold empty for pharmaceuticals ; germicides; greases for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal oils; medicinal herbs; Lotions for pharmaceutical purposes, namely, anti-bacteria hand washing solution, oral washings, gynecological washings, anorectal washings; Ointments for pharmaceutical purposes, namely, sunburn ointments, anti-inflammatory ointments, hemorrhoidal ointments, frostbite salve for pharmaceutical purposes, eye ointments; Pectin for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; herbs teas for medicinal purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; first-aid boxes, filled; medicinal roots; medicinal herbal preparations, namely, tonics medicine; sedatives; soporifics; sugar for medical purposes; Biological preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medical preparations for slimming purposes; by-products of the processing of cereals for dietetic or medical purposes; medicines for dental purposes; Diagnostic preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medicinal drinks; ferments for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; Dietary fiber to aid digestion; enzyme preparations for medical purposes; amino acids for pharmaceutical purposes; mouthwashes for medical purposes; appetite suppressants for medical purposes; adjuvants for medical purposes; Weight-reducing aid, namely, weight management supplements; Medicine for the treatment of sunburns; Food supplements, namely, antioxidants used for medicinal purposes; acne treatment preparation; Medicinal herbal preparations, namely, lysine electuary; oral rehydration salts; Medicinal liquor for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Medicinal herbal preparations, namely, ginseng electuary; Ginseng for medicinal use; Medicinal herbal preparations, namely, medlar; Dietetic beverages adapted for medicinal purposes, namely, weight-reducing tea; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, fruits; food for babies; milk powder for infants; air purifying preparations; Medicated animal washes; Veterinary preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Medicated animal feed; biocides; vermin destroying preparations; sanitary towels; wadding for medical purposes; medical dressings; rubber for dental purposes; teeth filling material; diaper for pets
- CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
-
5/29/2023 - a year ago
30 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Type: REM3
-
9/29/2018 - 5 years ago
29 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
9/11/2018 - 5 years ago
28 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
9/11/2018 - 5 years ago
27 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
8/29/2018 - 5 years ago
26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
5/29/2018 - 6 years ago
25 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
3/13/2018 - 6 years ago
24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
3/13/2018 - 6 years ago
23 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
2/21/2018 - 6 years ago
22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
2/10/2018 - 6 years ago
21 - REFUSAL PROCESSED BY IB
Type: RFNT
-
2/1/2018 - 6 years ago
20 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
1/13/2018 - 6 years ago
19 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
1/12/2018 - 6 years ago
18 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
1/12/2018 - 6 years ago
17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
12/21/2017 - 6 years ago
16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
12/21/2017 - 6 years ago
15 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
12/21/2017 - 6 years ago
14 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
12/7/2017 - 6 years ago
13 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/21/2017 - 6 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/20/2017 - 6 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
11/20/2017 - 6 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/22/2017 - 6 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
9/1/2017 - 6 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
9/1/2017 - 6 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
8/30/2017 - 6 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
8/29/2017 - 6 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/25/2017 - 6 years ago
4 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
8/21/2017 - 6 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/21/2017 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
8/17/2017 - 6 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR